189 related articles for article (PubMed ID: 31271269)
1. Leveraging the power of non-radium radionuclide treatments in bone metastases.
Thapa P; Basu S
Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):159-169. PubMed ID: 31271269
[TBL] [Abstract][Full Text] [Related]
2. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
Rubini G; Nicoletti A; Rubini D; Asabella AN
Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
[TBL] [Abstract][Full Text] [Related]
3. The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases.
Tomblyn M
Cancer Control; 2012 Apr; 19(2):137-44. PubMed ID: 22487976
[TBL] [Abstract][Full Text] [Related]
4. [Targeted radionuclide therapy for castration-resistant prostate cancer].
Nakamura K; Ohga S; Sasaki T; Baba S; Honda H
Nihon Rinsho; 2014 Dec; 72(12):2181-5. PubMed ID: 25518355
[TBL] [Abstract][Full Text] [Related]
5. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
Bruland ØS; Nilsson S; Fisher DR; Larsen RH
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
[TBL] [Abstract][Full Text] [Related]
6. Systemic Radiotherapy of Bone Metastases With Radionuclides.
Murray I; Du Y
Clin Oncol (R Coll Radiol); 2021 Feb; 33(2):98-105. PubMed ID: 33353771
[TBL] [Abstract][Full Text] [Related]
7. Radium-223 dichloride for the treatment of metastatic prostate cancer.
Turner PG; O'Sullivan J
Expert Opin Pharmacother; 2014 Oct; 15(14):2105-11. PubMed ID: 25186336
[TBL] [Abstract][Full Text] [Related]
8. Radium-223 dichloride in clinical practice: a review.
Florimonte L; Dellavedova L; Maffioli LS
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning.
Ahmadzadehfar H; Essler M; Rahbar K; Afshar-Oromieh A
PET Clin; 2018 Oct; 13(4):491-503. PubMed ID: 30219184
[TBL] [Abstract][Full Text] [Related]
10. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.
Handkiewicz-Junak D; Poeppel TD; Bodei L; Aktolun C; Ezziddin S; Giammarile F; Delgado-Bolton RC; Gabriel M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):846-859. PubMed ID: 29453701
[TBL] [Abstract][Full Text] [Related]
11. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.
Pandit-Taskar N; Larson SM; Carrasquillo JA
J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987
[TBL] [Abstract][Full Text] [Related]
12. Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions.
Dash A; Das T; Knapp FFR
Curr Med Chem; 2020; 27(19):3187-3249. PubMed ID: 30714520
[TBL] [Abstract][Full Text] [Related]
13. [Radium-223 treatment of bone metastases from castration-resistant prostate cancer].
Mortensen J; Højgaard L
Ugeskr Laeger; 2014 Jul; 176(30):1399-402. PubMed ID: 25292232
[TBL] [Abstract][Full Text] [Related]
14. Bone-targeting radiopharmaceuticals including radium-223.
Brady D; Parker CC; O'Sullivan JM
Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760
[TBL] [Abstract][Full Text] [Related]
15. [Radionuclides for metastatic bone pain palliation].
Lass P
Pol Merkur Lekarski; 2002 Oct; 13(76):277-80. PubMed ID: 12557429
[TBL] [Abstract][Full Text] [Related]
16. Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.
Patel CM; Wadas TJ; Shiozawa Y
Molecules; 2021 Apr; 26(8):. PubMed ID: 33918705
[TBL] [Abstract][Full Text] [Related]
17. [Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases].
Tauber R; Gschwend J; Scheidhauer K; Eiber M; Krönke M
Urologe A; 2017 Jan; 56(1):24-31. PubMed ID: 28058455
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.
Wale DJ; Viglianti BL; Gross MD; Ferretti A; Rubello D; Wong KK
Am J Clin Oncol; 2019 Jan; 42(1):99-106. PubMed ID: 30204613
[TBL] [Abstract][Full Text] [Related]
19. Antitumor Activity of Novel Bone-seeking, α-emitting
Juzeniene A; Bernoulli J; Suominen M; Halleen J; Larsen RH
Anticancer Res; 2018 Apr; 38(4):1947-1955. PubMed ID: 29599310
[TBL] [Abstract][Full Text] [Related]
20. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
Badawi JK
Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]